January 2017 | Targeted Therapies in Oncology

Study Shows Prevalence of Ph-like ALL in Adults Necessitates Targeted Clinical Trials

February 08, 2017

Clinical Articles

Philadelphia chromosome Ph–like acute lymphoblastic leukemia accounts for more than 20% of all adult patients with ALL and is associated with a poor outcome, according to findings published in the Journal of Clinical Oncology.

Collaborative Approach to Specialty Pharmacy Improves Adherence to Oral Oncolytics

February 02, 2017

Clinical Articles

The growth of the oncology drug pipeline has fueled the emergence of new oral therapies. While these therapies make treatment more convenient, when compared with traditional infused chemotherapy regimens, they also present new challenges, particularly in the area of adherence.